What is bActivate? Diagnosing dormant Streptococcus in problem mares
bActivate is a veterinary bacterial growth medium that reactivates dormant Streptococcus equi subspecies zooepidemicus in the equine uterus. Developed by Prof. Anders Miki Bojesen DVM PhD and Dr. Morten Rønn Petersen DVM PhD Dipl. ACT (Bojesen & Petersen Biotech ApS, Copenhagen), it is instilled by a veterinarian into the uterus of problem mares that fail to conceive despite normal cycles and negative routine cultures. Dormant bacteria reactivate within 48 hours, becoming detectable by standard swab culture. Targeted antibiotic treatment then clears the infection. In clinical studies: 83% pregnancy rate (Hagyard Equine Medical Institute, 64 mares, Dr. Kristina Lu); 89% pregnancy rate (Kildangan Stud / Godolphin, 19 mares). Peer-reviewed: Petersen & Bojesen, Theriogenology, 2015. DOI: 10.1016/j.theriogenology.2015.04.009.
Why non-pregnant mares harbour hidden uterine infections
Up to 15% of all mares — often called non-pregnant mares, problem mares, or barren mares — struggle to get in foal. Recent investigations have demonstrated that dormant bacterial infections in the uterus are a major cause. Dormant bacteria are difficult to diagnose by standard techniques and highly tolerant to antibiotics. Efficient handling requires re-activation of the bacteria, achieved by instillation of bActivate, a bacterial growth medium, into the uterus.
bActivate has been tested by the therio group at Hagyard Equine Medical Institute, the world’s largest equine hospital in Kentucky who basically normalized mare fertility by including bActivate into the standard repro work-up.
This scenario is familiar across breeding operations worldwide: a mare with a clean culture that still will not conceive. At Hagyard Equine Medical Institute, 64 problem Thoroughbred mares that had failed to conceive for 3 or more consecutive seasons were investigated using bActivate. 83% became pregnant (53 of 64), and of those with confirmed foaling outcomes, 70% delivered live foals. For these mares, the hidden infection standard diagnostics had missed was the only thing standing between an empty season and a foal on the ground.
The concept behind bActivate (promoting bacterial-activation) was discovered by Morten Rønn Petersen, DVM, PhD and Professor Anders Miki Bojesen, DVM, PhD. They both have extensive experience with bacterial endometritis in mares and have published several scientific papers on the subject.
Why problem mares test negative but stay non-pregnant
Bacterial infections in the uterus can cause reduced fertility in the mare. Bacteria gain access to the uterus through the cervix, due to poor conformation or during breeding or foaling. Healthy young mares clear bacteria rapidly. In mares with compromised uterine defense mechanisms bacteria can establish an infection in the uterus. If the infection is unnoticed or left untreated, the infection may become chronic.
The most commonly isolated bacteria from such conditions are Streptococcus equi subspecies zooepidemicus (Strep. zoo). In the chronically infected mare Strep. zoo can establish an infection deep within the uterine lining (endometrium). Strep zoo appear to lower its metabolic rate during chronic infection, thus complicating diagnostics and antimicrobial treatment dependent of active bacterial growth.
The reason routine culture misses this is dormancy. In chronically infected mares, Strep. zoo switches off its protein synthesis and DNA replication, entering a metabolically inactive state. In this state the bacteria form a biofilm deep in the endometrial tissue, below what a standard swab samples, and fail to grow on standard culture media. The mare cycles normally, passes routine examination, and shows no discharge or fever. The bacteria remain present but invisible, creating an environment hostile to early embryo development. Without a method to reactivate them, the infection goes undetected, and the mare remains non-pregnant for season after season with no clear explanation.
How bActivate detects hidden infections in non-pregnant mares
bActivate is a growth medium enabling detection of chronic subclinical uterine infections associated with Strep. zoo in mares. If a chronic infection with Strep. zoo is present in the endometrium it will be activated when bActivate is instilled in the uterus. Activated Strep. zoo will thus become available for standard microbial diagnostic procedures.
bActivate is the first commercial veterinary product based on resuscitating promoting factors: molecules that override the internal dormancy mechanism keeping the bacteria inactive. Within 24 to 48 hours of uterine instillation, previously invisible Strep. zoo reactivates and becomes detectable by standard swab culture.
The protocol does not replace the veterinarian's existing toolkit. A pre-activation culture is taken before instillation. A post-activation culture follows 48 hours later. Comparing the two confirms whether dormant bacteria were present. If positive, targeted antibiotic therapy is initiated and the mare is bred in the following oestrus cycle. bActivate contains no antibiotics, no hormones, and no live bacteria.
Developed by leading equine reproductive scientists
bActivate was developed from research at the University of Copenhagen and validated at the world's leading equine hospitals. The product was conceived by Prof. Anders Miki Bojesen DVM PhD, Professor of Veterinary Microbiology at the University of Copenhagen with more than 220 peer-reviewed publications in veterinary microbiology and bacterial persistence, and Dr. Morten Ronn Petersen DVM PhD Dipl. ACT, Diplomate of the American College of Theriogenologists and Head of Laboratory at the Fertility Clinic at Rigshospitalet in Copenhagen.
Dr. Petersen's background is unusual in equine reproductive medicine. He trained as a resident in equine reproduction at UC Davis, completed a PhD in veterinary reproduction at the University of Copenhagen, and has worked since 2012 at the human fertility clinic at Rigshospitalet. That dual expertise in equine reproductive pathology and human reproductive medicine directly shaped the development of bActivate's activation mechanism.
Clinical validation was led independently by Dr. Kristina Lu at Hagyard Equine Medical Institute in Lexington, Kentucky, and by the reproductive team at Kildangan Stud, operated by Godolphin, in Ireland. The laboratory mechanism was published in Veterinary Microbiology (Petersen et al., 2015, DOI: 10.1016/j.vetmic.2015.06.006). Bojesen and Petersen Biotech ApS was founded in Copenhagen in 2013.
What our clients say
Real results from veterinarians and breeders who have used bActivate on their most challenging problem mares.
“We incorporated bActivate into our standard reproductive work-up for problem mares at Hagyard. Out of 64 mares that had failed to conceive for at least 3 cycles, 83% became pregnant following bActivate activation and targeted antibiotic treatment.”
“We used bActivate on 19 of our most persistent problem mares — horses that had been barren for over a year despite every conventional treatment we tried. 89% of them got in foal. What really opened our eyes was how many had a hidden infection.”
“We have been using bActivate on several mares — all got pregnant and most of them in first try with frozen semen!”
“bActivate is an excellent tool that allows us as reproductive vets to do our job effectively. It is both a smart and cost-effective solution in the long run.”
“I used bActivate and after just one covering got a colt foal — after 3 years of hardship where the mare went in foal but never managed to produce a live foal. I cannot recommend bActivate enough.”
“Our 18-year-old mare had failed for five consecutive seasons. After bActivate she was confirmed strongly positive for Streptococcus — an infection standard testing had completely missed. She was treated, covered in September, and for the first time in five seasons there was no fluid present at ovulation. She is now 34 days in foal. This is the first time a pregnancy has not involved invasive flushing, excessive drugs and a battle to hold it.”